Medicines under additional monitoring in the European Union.

CONCLUSIONS: The group of medicines subject to additional monitoring mainly  includes new active substances. The most common pharmacological group is antineoplastic and immunomodulating agents. The postauthorisation safety  study has already produced information published by the Spanish Agency of  Medicines and Medical Devices.
PMID: 30624169 [PubMed - in process]

Source: Farmacia Hospitalaria - January 1, 2019 Category: Drugs & Pharmacology Authors: Manso G, Neira F, Ortega S, Martín Arias LH, Sainz M, Salgueiro E Tags: Farm Hosp Source Type: research